We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Thermo Fisher Scientific
TMO
$248B
| $25.6M | 0.05% |
63,046
-12,315
| -16% | -$5.15M |
2013 Q2
48 quarters
|
|
377
XP
XP
$15.2B
| $25.5M | 0.05% |
1,260,707
+1,250,037
| +11,715% | +$21.6M |
2024 Q4
2 quarters
|
|
378
T-Mobile US
TMUS
$165B
| $25.2M | 0.05% |
105,737
+94,801
| +867% | +$23.1M |
2013 Q4
46 quarters
|
|
379
United Rentals
URI
$65B
| $25.1M | 0.05% |
33,332
+22,341
| +203% | +$14.9M |
2013 Q2
48 quarters
|
|
380
lululemon athletica
LULU
$10.8B
| $24.9M | 0.05% |
104,980
+99,664
| +1,875% | +$27.5M |
2018 Q1
29 quarters
|
|
381
American Airlines Group
AAL
$7.87B
| $24.8M | 0.05% |
2,213,929
+714,591
| +48% | +$7.65M |
2023 Q2
8 quarters
|
|
382
NVR
NVR
$15.1B
| $24.8M | 0.05% |
3,362
-371
| -10% | -$2.66M |
2013 Q2
48 quarters
|
|
383
DoubleVerify
DV
$2.11B
| $24.7M | 0.05% |
1,648,952
-14,869
| -0.9% | -$204K |
2023 Q1
9 quarters
|
|
384
ICU Medical
ICUI
$4.09B
| $24.5M | 0.05% |
185,494
-18,034
| -9% | -$2.44M |
2014 Q4
42 quarters
|
|
385
DELISTED
GMS Inc
GMS
| $24.4M | 0.05% |
224,700
-315,238
| -58% | -$24.4M |
2017 Q4
30 quarters
|
|
386
Marathon Petroleum
MPC
$134B
| $24.3M | 0.05% |
145,993
-59,618
| -29% | -$8.94M |
2013 Q2
48 quarters
|
|
387
Life360
LIF
$3.37B
| $24.2M | 0.05% |
371,461
+322,688
| +662% | +$16.6M |
2024 Q4
2 quarters
|
|
388
StoneCo
STNE
$2.66B
| $24.1M | 0.05% |
1,501,896
+318,845
| +27% | +$4.25M |
2019 Q2
24 quarters
|
|
|
OS
389
DELISTED
OneStream Inc
OS
| $24.1M | 0.05% |
850,000
| – | – |
2024 Q3
3 quarters
|
|
390
Albertsons Companies
ACI
$6.17B
| $24M | 0.05% |
1,116,615
+227,257
| +26% | +$4.94M |
2020 Q2
20 quarters
|
|
391
Alphabet (Google) Class C
GOOG
$4.28T
| $24M | 0.05% |
135,332
-9,337
| -6% | -$1.54M |
2013 Q2
48 quarters
|
|
392
Citizens Financial Group
CFG
$26.3B
| $23.7M | 0.04% |
530,529
-133,122
| -20% | -$5.24M |
2015 Q4
38 quarters
|
|
393
Brown & Brown
BRO
$21.5B
| $23.6M | 0.04% |
213,101
+199,024
| +1,414% | +$22.4M |
2013 Q2
48 quarters
|
|
394
Lantheus
LNTH
$6.54B
| $23.5M | 0.04% |
286,748
-25,413
| -8% | -$2.23M |
2021 Q3
15 quarters
|
|
395
DELISTED
ChampionX
CHX
| $22.9M | 0.04% |
921,327
-109,912
| -11% | -$2.77M |
2018 Q2
28 quarters
|
|
396
Okta
OKTA
$38.2B
| $22.7M | 0.04% |
227,110
+111,153
| +96% | +$11.9M |
2022 Q2
12 quarters
|
|
397
Fiverr
FVRR
$304M
| $22.6M | 0.04% |
770,000
| – | – |
2019 Q2
24 quarters
|
|
398
Braze
BRZE
$3.23B
| $22.6M | 0.04% |
803,325
+18
| +0% | +$569 |
2023 Q3
7 quarters
|
|
399
Workday
WDAY
$45B
| $22.5M | 0.04% |
93,870
-64,320
| -41% | -$15.7M |
2013 Q2
48 quarters
|
|
400
Sarepta Therapeutics
SRPT
$1.75B
| $22.4M | 0.04% |
1,308,199
+1,016,069
| +348% | +$43.3M |
2019 Q4
22 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.